Shares of Novo Nordisk slumped sharply on Wednesday, February 4, after the global pharma major unexpectedly pre-released its 2026 outlook, dampening rising optimism around...
Novo Nordisk India has entered into a strategic partnership with Emcure Pharmaceuticals to launch Poviztra®, the second brand of Wegovy® (semaglutide injection 2.4 mg),...
Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs like Zepbound...